ENX:EURONEXT PARISEuronext NV Analysis
Data as of 2026-03-13 - not real-time
€139.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Euronext trades at €139, comfortably above its 20‑day (≈€134.6) and 200‑day (≈€133.1) moving averages, indicating short‑term momentum, yet the MACD histogram is negative and the signal line is bearish, while volume is trending lower and the RSI sits at 62, suggesting the rally may be losing steam near the €142.4 resistance. The stock’s trailing P/E of 22 is well above the industry average of 16, and the DCF‑derived fair value of €130.2 places the current price slightly premium, though forward earnings are expected to rise to €8.52, compressing the forward P/E to 16 and supporting the analyst consensus “Buy” with median target €150.
A voluntary share‑exchange offer to acquire all shares of Hellenic Exchanges expands ENX’s footprint in Southern Europe, complementing its already diversified pan‑European platform, while a pending lawsuit from Italy’s CDP introduces moderate regulatory risk. The company delivers a solid 35% profit margin, a 46% dividend payout yielding 2.1%, and a healthy cash position that underpins dividend sustainability, positioning ENX as a blend of growth and value with attractive upside potential despite heightened volatility.
A voluntary share‑exchange offer to acquire all shares of Hellenic Exchanges expands ENX’s footprint in Southern Europe, complementing its already diversified pan‑European platform, while a pending lawsuit from Italy’s CDP introduces moderate regulatory risk. The company delivers a solid 35% profit margin, a 46% dividend payout yielding 2.1%, and a healthy cash position that underpins dividend sustainability, positioning ENX as a blend of growth and value with attractive upside potential despite heightened volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and decreasing volume
- Price approaching technical resistance
- RSI indicating overbought conditions
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Successful acquisition of Hellenic Exchanges expanding market reach
- Forward earnings growth compressing forward P/E to 16
- Analyst median target of €150 implying ~8% upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend payout with 46% payout ratio
- Strong operating margins and profit margins above 30%
- Diversified European footprint reducing single‑country exposure
Key Metrics & Analysis
Financial Health
Revenue Growth9.80%
Profit Margin35.35%
P/E Ratio22.1
ROE15.11%
ROA0.19%
Debt/Equity71.83
P/B Ratio3.1
Op. Cash Flow€812.1M
Free Cash Flow€740.8M
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI62.4
Support€120.00
Resistance€142.40
MA 20€134.55
MA 50€126.40
MA 200€133.11
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value€130.23
Target Price€147.94
Upside/Downside6.43%
GradeFair
TypeBlend
Dividend Yield2.10%
Risk Assessment
Beta0.14
Volatility29.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.